About Us
Medical Blog
  • New Video Resources on Inter Partes Review (IPRs)

    Since 2012, Inter Partes Review ("IPR") has emerged as one of the most significant new procedures in patent law. An IPR is a proceeding in the Patent Office, and allows a party to challenge an issued patent on certain prior art grounds.  If successful, the challenging party can invalidate some or all of the patent claims. IPRs can be an alternative to challenging a patent in court, although oft ...
  • Potential Repeal of Medical Device Tax

    With the upcoming Republican-dominated Presidency and Congress in 2017, the Affordable Care Act, or at least parts of it, look to be on the chopping block.  One of the changes that may be forthcoming is a repeal of the 2.3% medical device excise tax.  While currently being suspended through 2017, under the present law the medical device tax would be reinstated in 2018. Some producers of med ...
  • Myriad Genetics Announces an Assay that Identifies Patients for Olaparib Treatment

    Salt Lake City-based Myriad Genetics, Inc. announced that its BRACAnalysis CDx® test accurately identifies patients with ovarian cancer for a second-line treatment with olaparib. The announcement came as a result of a clinical study finding that the Myriad diagnostic device accurately identifies patients for olaparib treatment. Commenting on the results of the clinical study, Johnathan Lancast ...
Conferences